# Multicenter Observational Study Taulí-T1 Classification for the Management of pT1 Rectal Adenocarcinoma

> **NCT06218108** · — · UNKNOWN · sponsor: **Corporacion Parc Tauli** · enrollment: 317 (estimated)

## Conditions studied

- Rectal Cancer Stage I

## Interventions

- **DIAGNOSTIC_TEST:** Taulí-T1 versus conventional classifications

## Key facts

- **NCT ID:** NCT06218108
- **Lead sponsor:** Corporacion Parc Tauli
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-02
- **Primary completion:** 2025-10-06
- **Final completion:** 2026-01-05
- **Target enrollment:** 317 (ESTIMATED)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06218108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06218108, "Multicenter Observational Study Taulí-T1 Classification for the Management of pT1 Rectal Adenocarcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06218108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*